Better survival of renal cell carcinoma in patients with inflammatory bowel disease

BACKGROUND: Immunosuppressive therapy may impact cancer risk in inflammatory bowel disease (IBD). Cancer specific data regarding risk and outcome are scarce and data for renal cell carcinoma (RCC) are lacking. We aimed(1) to identify risk factors for RCC development in IBD patients (2) to compare RC...

Descripción completa

Detalles Bibliográficos
Autores principales: Derikx, Lauranne A.A.P., Nissen, Loes H.C., Drenth, Joost P.H., van Herpen, Carla M., Kievit, Wietske, Verhoeven, Rob H.A., Mulders, Peter F.A., Hulsbergen-van de Kaa, Christina A., Boers-Sonderen, Marye J., van den Heuvel, Tim R.A., Pierik, Marieke, Nagtegaal, Iris D., Hoentjen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742003/
https://www.ncbi.nlm.nih.gov/pubmed/26447542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742003/
https://www.ncbi.nlm.nih.gov/pubmed/26447542

Ejemplares similares